The objective of this study was to assess early recanalization rates following intravenous recombinant tissue plasminogen activator (rt-PA) therapy by magnetic resonance angiography (MRA) or digital subtraction angiography (DSA) in patients with acute ischemic stroke in order to plan a clinical investigation for a newly de veloped sonothrombolysis system. Methods: We retrospectively enrolled consecutive patients with acute ischemic stroke who were treated with in travenous rt-PA. Early recanalization within 2 hours and 24 hours after the initiation of rt-PA was evaluated by modified Mori grade on follow-up MRA or Thrombolysis in Cerebral Infarction (TICI) score on follow-up DSA. Results: A total of 384 patients were enrolled (243 men, age 74 ± 13 years) in the study. Patients were subdivid ed into groups based upon arterial location as follows: 63 patients in the internal carotid artery (ICA), 181 in the middle cerebral artery (MCA [M1 and M2 segments]), 5 in the anterior cerebral artery (ACA), and 14 in the posterior cerebral artery (PCA). Among patients with major artery occlusion (ICA, MCA, ACA, or PCA), the rates of recanalization were 37.2% within 2 hours and 57.4% within 24 hours; 8 of 232 patients (3.4%) had symptomatic intracranial hemorrhage within the initial 36 hours, and 76 of 225 patients (33.8%) had a favor able functional outcome (modified Rankin Scale (mRS) 0-1) at 3 months. Conclusions: We assessed early recanalization rates and clinical outcome following intravenous rt-PA therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.